THE ALZHEIMER'S PLAQUES, TANGLES AND MEMORY DEFICITS MAY HAVE A COMMON ORIGIN - PART III: ANIMAL MODEL

Ming Chen

Department of Pharmacology and Therapeutics, University of South Florida , College of Medicine, Tampa, Florida 33612, and Medical Research Service (151), Bay Pines VA Medical Center, St. Petersburg, Florida 33744

Received 6/9/98 Accepted 6/17/98

6. REFERENCES

1. Selkoe, D. J. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271, 18295-18298 (1996)

2. Yankner, B. A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932 (1996)

3. Trojanowski, J. Q. and Lee, V. M-Y. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesion: focusing on phosphatases. FASEB J 9, 1570-1576 (1995)

4. Terry, R. D. Masliah, E. Salmon, D. P. Butters, N. DeTeresa, R. Hill, R. Hansen, L. A. and Katzman, R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580 (1991)

5. Greenberg, B. D, Savage, M. J, Howland, D. S. Ali, S. M. Siedlak, S. L. Perry, G. Siman, R. and Scott, R. W. APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology. Neurobiol Aging 17, 153-171 (1995)

6. Price, D. L. and Sisodia, S. S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 21, 479-505 (1998)

7. Chen, M. Is Alzheimer's disease associated with a decreased intracellular level of calcium? Front Biosci 3, let1-2 (1998) (http://www.bioscience.org/v3/let/chen/list.htm)

8. Chen, M. The Alzheimer's plaques, tangles and memory dificits may have a common origin-Part I: A calcium deficit hypothesis. Front Biosci 3, a27-31 (1998) (http://www.bioscience.org/3/a/chen/list.htm)

9. Chen, M. The Alzheimer's plaques, tangles and memory dificits may have a common origin- Part II: therapeutic rationale. Front Biosci 3, a 32-37 (1998) (http://www.bioscience.org/3/a/chen1/list.htm)

10. Kandel, E. R. and Schwartz, J. H. Principles of Neural Science. 3rd edn. Simon & Schuester, New York (1991)

11. Cotman, C. W. Monaghan, D. T. and Ganong, A. H. Exitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Ann Rev Neurosci 11, 61-80 (1988)

12. Cotman, C. W. Bridges, R. J. Taube, J. S. Clark, A. S. Geddes, J. W. and Monaghan, D. T. The role of the NMDA receptor in central nervous system plasticity and pathology. J NIH Res 1, 65-74 (1989)

13. Morris, R. G, Anderson, E. Lynch, G. and Baudry, M. Selective impairment of learning and blockage of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774-776 (1986)

14. Spangler, E. L. Bresnahan, E. L. Garofalo, P. Muth, N. J. Heller, B. and Ingram, D. K. NMDA receptor channel antagonism by dizocilpine (MK-801) impairs performance of rats in aversively motivated complex maze tasks. Pharmacol Biochem Behav 404, 949-958 (1991)

15. Bischoff, C. and Tiedtke, P. I. Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks. Eur J Pharmacol 213, 267-273 (1992)

16. Ferger, D. and Krieglstein, J. Determination of intracellular Ca2+ concentration can be a useful tool to predict neuronal damage and neuroprotective properties of drugs. Brain Res 732, 87-94 (1996)

17. Rubin, Y. LaPlaca, M. C. Smith, D. H. Thibault, L. E. and Lenkinski, R. E. The effect of N-acetylaspartate on the intracellular free calcium concentration in NTera2-neurons. Neurosci Lett 198, 109-112 (1995)

18. Holley, L. A. Dudchenko, P. and Sarter, M. Attenuation of muscarinic receptor blockade-induced impairment of spatial delayed alteration performance by the triazole MDL26479. Psychopharmacol 109, 223-230 (1992)

19. Ukai, M. Itoh, J. Kobayashi, T. Shinkai, N. and Kameyama, T. Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice. Behav Brain Res 83, 169-172 (1997)

20. Maren, S. and Baudry, M. Properties and mechanisms of long-term synaptic plasticity in the mammalian brain: relationships to learning and memory. Neurobiol Learning Memory 63, 1-18 (1992)

21. Craig, C. R. and Stitzel, R. E. Modern Pharmacology 5th edn. Little, Brown & Co. Boston (1997)

22. Schmage, N. and Bergener, M. Global rating, symptoms, behavior, and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes. Intl Psychogeriatrics (4 Suppl) 1, 89-99 (1992).

23. Mattson, M. P. Calcium as sculptor and destroyer of neural circuitry. Exp Gerontol 27, 29-49 (1992)

24. Maurice, T. Bayle, J. and Privat, A. Learning impairment following acute administration of the calcium channel antagonist nimodipine in mice. Behav Pharmacol 6, 167-175 (1995)

25. Maurice, T. Su, T. P. Parish, D. W. and Privat, A. Prevention of nimodipine-induced impairment of learning by the selective sigma ligand PRE-084. J. Neural Transm 102, 1-18 (1995)

26. Nikolaev, E. and Kaczmarek, L. Disruption of two-way acitive avoidance behavior by nimodipine. Pharmcol Biochem Behav 47, 757-759 (1994)

27. Deyo, R. A. Nix, D. A. and Parker, T. W. Nifedipine blocks retention of a visual discrimination task in chicks. Behav Neural Biol 57, 260-262 (1992)

28. Lynch, G. Larson, J. Kelso, S. Barrionuevo, G. and Schottler, F. Intracellular injections of EGTA block induction of long-term potentiation. Nature 321, 519-522 (1983)

29. Malenka, R. C. Kauer, J. A. Zucker, R. S. and Nicoll, R. A. Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science 242, 81-84 (1988)

30. Shivers, B. D. Hilbich C. Multhaup, G. Salbaum, M. Beyreuther, K. and Seeburg, P. H. Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J 7, 1365-1370 (1988)

31. Etienne, P. and Baudry, M. Calcium dependent aspects of synaptic plasticity, excitatory amino acid neurotransmission, brain aging and schizophrenia: a unifying hypothesis. Neurobiol Aging 8, 362-366 (1987)

32. Konradi, C. Leveque, J-C. and Hyman, S. E. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci 16, 4231-4239 (1996)

33. Eckert, A. Gann, H. Riemann, D. Aldenhoff, J. and Muller, W. E. Platelet and lymphocyte free intracellular calcium in affective diorders. Eur Arch Psychiatry Clin Neurosci 243, 235-239 (1994)

34. Garza-Trevino, E. S. Overall, J. E. and Hollister, L. E. Verapamil versus lithium in acute mania. Am J Psychiatry 149, 121-122 (1992)

35. Dubovsky, S. L. Calcium antagonists in manic-depressive disease. Neuropsychobiol 27, 184-192 (1993)

36. Rowland, L. P. Eds. Merritt's Textbook of Neurology. 9th edn. Williams & Wilkins, Baltimore (1995)

37. Lamberts, S. W. van den Beld, A. W. and van der Lely, A-J. The endocrinology of aging. Science 278, 419-424 (1997)

38. Sczekan, S. R. and Strumwasser, F. Antipsychotic drugs blocks IP3-dependent Ca2+-release from rat brain microsomes. Biol Psychiatry 40, 497-502 (1996)

39. Wisniewski, H. M. Constantinidis, J. Wegiel, J. Bobinski, M. and Tarnawski, M. Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics. Alzheimer Dis. Assoc. Disorders 8, 211-227 (1994)

40. Gong, C-X. Shaikh, S. Grundke-Iqbal, I. and Iqbal, K. Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormality phosphorylated tau by neuroleptics. Brain Res 741, 95-102 (1996)

41. Cohen, P. The structure and regulation of protein phosphatases. Ann Rev Biochem 58, 453-508 (1989)

42. Corder, E. Saunders, A. M. Strittmatter, W. J. Schmechel, D. E. Gaskell, P. C. Small, G. W. Roses, A. D. and Haines, J. L. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923 (1993)